wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q46175382-1DEBE560-D18C-4DA4-8BC7-0A6E725A9359
Q46175382-1DEBE560-D18C-4DA4-8BC7-0A6E725A9359
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46175382-1DEBE560-D18C-4DA4-8BC7-0A6E725A9359
Evaluation of the safety and tolerability of rivaroxaban in dogs with presumed primary immune-mediated hemolytic anemia.
P2860
Q46175382-1DEBE560-D18C-4DA4-8BC7-0A6E725A9359
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46175382-1DEBE560-D18C-4DA4-8BC7-0A6E725A9359
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a4f5b13a016b3e329e2616236b4af491d6c2bf11
P2860
Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002)